切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - MDM2 - Prk - Delayed rectifier outward potassium current (IKr) - Inward Rectifier Potassium (Kir) Channels

11件产品中的 1-10

页面
每页
清除全部
  1. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  2. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  3. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  4. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  5. Dofetilide
    A8417 Dofetilide
     2 Citation
    中文名: 多非利特
    Target: Delayed rectifier outward potassium current (IKr)
    Summary: 钾通道抑制剂
      ≥21.15 mg/mL
      insoluble in H2O
  6. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  7. GSK690693
    A5072 GSK690693
    Target: Akt|PKC|PKG|PKA|Prk
    Summary: ATP竞争性的Pan-AKT抑制剂
      ≥21.25 mg/mL
      insoluble in H2O
  8. RG7112
    A3762 RG7112
     5 Citation
    Target: MDM2
    Summary: MDM2抑制剂
      ≥36.4 mg/mL
      insoluble in H2O
  9. Nutlin-3
    A4228 Nutlin-3
    Target: MDM2
    Summary: MDM2 拮抗剂
      ≥58.2 mg/mL
      insoluble in H2O
  10. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页